SAWAI GROUP HOLDINGS CO LTD revenue for the last year amounted to 176.86 B JPY, the most of which — 49.13 B JPY — came from its highest performing source at the moment, Circulatory Organ Drug, the year earlier bringing 51.41 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought SAWAI GROUP HOLDINGS CO LTD 163.70 B JPY, and the year before that — 163.84 B JPY.